FDA Regulatory Framework For Ephedra Ban Expected To Get Court Review
This article was originally published in The Tan Sheet
FDA's regulatory framework for removing dangerous dietary supplements from the market under the Dietary Supplement Health & Education Act's "unreasonable risk" standard will be issued shortly by the agency
You may also be interested in...
Challenges to the risk-benefit analysis FDA applied in banning the use of ephedra will continue following the Supreme Court's May 14 refusal to hear Nutraceutical Corp.'s appeal, according to the firm's attorney and to industry trade groups
The president of Jarrow Formulas has formally challenged House Energy and Commerce Committee Chairman John Dingell, D-Mich., to back up claims that dietary supplements "are killing people," and says he does not expect Dingell will act on plans to conduct hearings on the Dietary Supplement Health and Education Act
NVE Pharmaceuticals is challenging FDA's ban of ephedra on the grounds the agency did not meet its burden of proving the ingredient unsafe under the Dietary Supplement Health & Education Act